Triple-negative breast cancer (TNBC), accounting for 15–20% of breast cancers, is defined by lack of expressions of progesterone receptors, estrogen receptors (ERs), and human epidermal growth factor receptor-2 (HER2)1. This evidence concerns the gene ERBB2 and breast carcinoma.